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LETTER TO THE EDITOR
Confidence intervals can be helpful
Sir - The use of confidence intervals has been promoted by
medical statisticians over the last decade (Gardner & Altman.
1986: Altman & Machin. 1993). but clinicians have been less
than enthusiastic in adopting them to report clinical research.
For example. a survey of 81 oncology papers found that only
27 included calculation of a confidence interval of a reported
response rate (Campbell. 1992). Many doctors consider
confidence intervals to be an unnecessary complication. How-
ever. in some circumstances. confidence intervals can be
useful in helping doctors make sense of their results. and the
paper by Cortesina et al. (1994) provides a useful case study.
Cortesina et al. (1994) studied patients with recurrent
squamous cell carcinoma of the head and neck treated by
interleukin 2 injected perilymphatically. In a randomised
trial. they found that 4 out of 16 patients (25%) responded
to a low dose of interleukin 2. and none out of 15 patients
responded to a high dose. They give their conclusion as
regression ... is achieved with a low but not with a high dose
of recombinant interleukin 2 ...' (quoted from the title). At
first sight. their conclusion may seem to be entirely
reasonable, with no further calculations needed. But with
only 15 patients given the high dose. can we really be sure
that it is ineffective? The finding of no responses in 15
patients certainly does not rule out a true response rate of
1% or 2%;o nor does it rule out a true response rate of 5%:
but what about true rates of 10% or 20% - can these be
ruled out?
Intuition tells us that if only. say. four patients had been
studied with each dose. to give responses rates of 25% and
0%. the sample sizes would be too small to give much
indication of the true response rates in future patients. Intui-
tion also tells us that if 1.000 patients had been studied to
give response rates of 25% and 0%. these would be fairly
accurate estimates of the true rates. It is in the intermediate
sample size of ten to a few hundred that confidence intervals
can be useful in interpreting the results from a sample. A
95% confidence interval can be loosely defined as a range of
values that will usually contain the true value. (More strictly.
if a large number of identical experiments were carried out
and a 95% confidence interval was calculated in each case.
then, in the long run. 95% of these confidence intervals
would include the true value: Gardner & Altman. 1986.) The
95% confidence interval for a response rate can be calculated
from a formula (Gardner & Altman. 1986: Altman. 1991). or
read off from a chart (Neave. 1981): the latter is preferable at
rates close to 0% or close to 100% where the formula most
commonly used becomes inaccurate.
Using the chart in Neave (1981). the 95% confidence
interval for the low dose of Cortesina et al.. where 4 16
responses were seen. is found to be 7-53%. This can be
interpreted as 'the true response rate in treating future
patients is probably somewhere between 7% and 53%, but it
may be less than 7% and may be higher than 53%'. The
95% confidence interval for the higher dose of Cortesina et
al. (1994), where 0 15 responses were seen, is 0-22%. again
using Neave (1981); so the true rate is probably somewhere
between 0% and 22%, but it may even be higher than 22%.
These ranges of uncertainty are wider than most people
would expect.
The response rates can be compared by a significance test.
and Fisher's exact test should be used rather than the chi-
squared test because of the small sample sizes (Altman.
1991), giving a non-significant P-value of 0.1. In general. it is
also possible to calculate a 95% confidence interval of the
difference in the response rates for the high and the low
doses (Gardner & Altman. 1986; Altman, 1991). but for the
results of Cortesina et al. (1994) the most commonly used
formula is inaccurate because of the small response rates and
small sample sizes, and a more elaborate method would be
required (Peskun, 1993).
So although Cortesina et al. found in their samples that
regression occurred with a low but not with a high dose of
interleukin 2, they cannot conclude that this will be true in
general. Instead, a more accurate and informative summarn
statement is that 'four responses occurred in the 16 patients
given the low dose (response rate 25%. 95% CI 7-53%) and
no responses in the 15 patients given the higher dose (95%
CI for response of 0-22%). difference not significant.
P = 0.1'.
yours etc,
I.R. Campbell
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